RespireRx Pharmaceuticals Inc (RSPI)

[Investor2014]

I too read the 10-Q and although much of the wording has sounded like misery and impending doom for a few years now, it seems clear to me that the drugs and indications holds great promise.

Did you notice this bit from the 10-Q:

RespireRx is considering an internal restructuring plan that contemplates spinning out the cannabinoid platform into what would initially be a wholly-owned subsidiary that the Company currently intends would ultimately have its own management team and board of directors. This spin-out company would be tasked with raising financing in order to develop and commercialize the dronabinol platform for the treatment of OSA.

Commercialising on the current cannabis wave of excitement may be a good way of gaining some traction!

I would prefer that the company raises money to successfully conduct a pivotal trial before entering into partnership/licensing deals.